If approved company’s prostate cancer therapy will be the first dual-action tablet available in EU
News
CN Bio launches single-organ higher throughput system PhysioMimix
Tech was created to overcome adoption obstacles currently reducing the use of predictive human liver models
PBD Biotech broadens patent for tuberculosis diagnostic
Africa-based trials for blood test which detects risk of disease progression are due to begin
Merck delivers vital data on evobrutinib
Treatment is an BTK inhibitor and has demonstrated a sound safety and tolerability profile
Sangamo’s ST-920 demonstrates evidence of clinical benefit
Phase 1/2 research shows that treatment could be very effective against Fabry disease
Michael J. Fox Foundation funding boost for Newel Health’s Soturi
Next phase of Newel Health’s digital therapeutics solution for Parkinson’s disease gains vital grant
Modus Therapeutics reveals latest sevuparin data
New top line data has emerged from the company’s phase 1b study evaluating potential for treating sepsis
UK atrial fibrillation research incorporates Brainomix
Research will analyse how Huawei’s wearable technology detects atrial fibrillation in post-stroke patients
CSL’s first gene therapy for haemophilia B approved
Boost for effected patients as HEMGENIX receives green light from European Commission
Trio of COVID-19 treatments receive NICE nod
Final draft guidance from NICE ensures people at highest risk will have access to COVID-19 therapies
Important milestone for Valneva’s chikungunya vaccine
VLA1553 is a single-dose, live-attenuated vaccine candidate targeting the highly dangerous chikungunya virus
Janssen reveals vital niraparib data
Research concerns the effect of niraparib when combined with abiraterone acetate plus prednisone
Pfizer update Lyme disease vaccine candidate
Research concerning candidate VLA15 has been discontinued across certain trial sites
BGF investment for early-stage businesses
Company has reported strong momentum among the early-stage businesses it invested in last year
AstraZeneca’s Evusheld not recommended for certain adults
Advice concerns the use of COVID-19 vaccine when treating specific vulnerable individuals
